Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

Market Cap	32.98B
Revenue (ttm)	23.80B
Net Income (ttm)	-1.77B
Shares Out	3.80M
EPS (ttm)	-466.00
PE Ratio	n/a
Forward PE	n/a
Dividend	75.00 (0.86%)
Ex-Dividend Date	Dec 27, 2024

Volume	30,440
Average Volume	53,227
Open	9,020.00
Previous Close	9,110.00
Day's Range	8,930.00 - 9,160.00
52-Week Range	8,460.00 - 12,690.00
Beta	0.90
RSI	38.58
Earnings Date	Mar 26, 2025

About KOSDAQ:036480

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1966
• Employees: 134
• Stock Exchange: KOSDAQ
• Ticker Symbol: 036480

Financial Performance

In 2024, KOSDAQ:036480's revenue was 23.80 billion, a decrease of -6.88% compared to the previous year's 25.56 billion. Losses were -1.77 billion, 160.3% more than in 2023.